• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幼儿急疹患者及其父母中人疱疹病毒6型持续性和排泄情况的前瞻性研究。

Prospective study of persistence and excretion of human herpesvirus-6 in patients with exanthem subitum and their parents.

作者信息

Suga S, Yoshikawa T, Kajita Y, Ozaki T, Asano Y

机构信息

Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.

出版信息

Pediatrics. 1998 Oct;102(4 Pt 1):900-4. doi: 10.1542/peds.102.4.900.

DOI:10.1542/peds.102.4.900
PMID:9755262
Abstract

OBJECTIVE

To elucidate persistence of human herpesvirus-6 (HHV-6) in the blood and excretion of the virus into several body fluids of patients with exanthem subitum (ES), and to examine serologic and virologic findings of the parents caring for the patients in the family setting.

MATERIALS AND METHODS

During a 15-month period, 20 infants from 20 families (11 boys and 9 girls; mean age, 7.7 months; range, 4-11 months) with primary HHV-6 infection and a typical clinical course of ES, and 15 parents from the 20 families (2 males and 13 females; mean age, 28.2 years; range, 21-34 years) were enrolled in the study and examined clinically and virologically. Primary infection with HHV-6 was confirmed by isolation of the virus from peripheral blood mononuclear cells (MNCs), and seroconversion or a significant increase in the antibody titers to HHV-6 by a neutralization test. Viral persistence or excretion was examined by amplifying the viral deoxyribonucleic acid (DNA) in serially collected peripheral blood MNCs, plasma, saliva, stool, and urine samples with a nested polymerase chain reaction method. Data on saliva from the parents were compared with those of 21 age-matched controls.

RESULTS

Twenty infants with virologically confirmed ES had HHV-6 DNA in MNCs persistently during and after the disease but in plasma only in the first 5 days of ES. The viral DNA was also detected persistently or intermittently in saliva and stool during and after the disease but rarely in urine. On the other hand, the 15 parents examined of the 20 infants had no HHV-6 viremia nor viral DNA in peripheral blood MNCs and plasma except 1, but half of them excreted viral DNA in saliva during and after ES. The frequency of excretion of viral DNA into saliva was not significantly different from that of 21 control parents. Only 1 of the 15 showed a fourfold increase in antibody titers to HHV-6 after possible exposure from their children.

CONCLUSIONS

After systemic replication of HHV-6 in the blood of patients with ES during the first 5 days of the disease, the virus is excreted into saliva and stool persistently or intermittently but rarely into urine. The presence of HHV-6 DNA in plasma suggested active infection with the virus. Excretion of the virus into the saliva of infants with ES and their parents suggests the source and transmission route of infection with HHV-6.

摘要

目的

阐明幼儿急疹(ES)患者血液中人类疱疹病毒6型(HHV - 6)的持续性以及该病毒向多种体液的排泄情况,并检查在家庭环境中照顾患者的父母的血清学和病毒学检查结果。

材料与方法

在15个月期间,招募了来自20个家庭的20名婴儿(11名男孩和9名女孩;平均年龄7.7个月;范围4 - 11个月),这些婴儿患有原发性HHV - 6感染且具有典型的ES临床病程,以及来自这20个家庭的15名父母(2名男性和13名女性;平均年龄28.2岁;范围21 - 34岁),对他们进行临床和病毒学检查。通过从外周血单个核细胞(MNC)中分离病毒以及通过中和试验检测血清转化或HHV - 6抗体滴度显著升高来确诊原发性HHV - 6感染。采用巢式聚合酶链反应方法扩增连续采集的外周血MNC、血浆、唾液、粪便和尿液样本中的病毒脱氧核糖核酸(DNA),以检查病毒的持续性或排泄情况。将父母唾液的数据与21名年龄匹配的对照者的数据进行比较。

结果

20例经病毒学确诊为ES的婴儿在疾病期间及之后,MNC中持续存在HHV - 6 DNA,但仅在ES的前5天血浆中存在。在疾病期间及之后,唾液和粪便中也持续或间歇性检测到病毒DNA,但尿液中很少检测到。另一方面,在检查的20例婴儿的15名父母中,除1人外,外周血MNC和血浆中均未检测到HHV - 6病毒血症及病毒DNA,但其中一半在ES期间及之后唾液中排泄病毒DNA。病毒DNA排泄到唾液中的频率与21名对照父母的频率无显著差异。15名父母中只有1人在可能接触其子女后,HHV - 6抗体滴度升高了四倍。

结论

在疾病的前5天,ES患者血液中HHV - 6进行全身复制后,该病毒持续或间歇性排泄到唾液和粪便中,但很少排泄到尿液中。血浆中存在HHV - 6 DNA提示病毒的活跃感染。ES婴儿及其父母唾液中病毒的排泄提示了HHV - 6感染的来源和传播途径。

相似文献

1
Prospective study of persistence and excretion of human herpesvirus-6 in patients with exanthem subitum and their parents.幼儿急疹患者及其父母中人疱疹病毒6型持续性和排泄情况的前瞻性研究。
Pediatrics. 1998 Oct;102(4 Pt 1):900-4. doi: 10.1542/peds.102.4.900.
2
Detection of human herpesvirus 6 DNAs in samples from several body sites of patients with exanthem subitum and their mothers by polymerase chain reaction assay.
J Med Virol. 1995 May;46(1):52-5. doi: 10.1002/jmv.1890460112.
3
Clinical features and virological findings in children with primary human herpesvirus 7 infection.原发性人类疱疹病毒7型感染儿童的临床特征及病毒学发现。
Pediatrics. 1997 Mar;99(3):E4. doi: 10.1542/peds.99.3.e4.
4
Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection.一名原发性人类疱疹病毒7型感染婴儿的临床特征及病毒排泄情况
Pediatrics. 1995 Feb;95(2):187-90.
5
Monitoring of human herpesviruses-6 and -7 DNA in saliva samples during the acute and convalescent phases of exanthem subitum.在出疹性疾病的急性和恢复期监测唾液样本中的人类疱疹病毒 6 型和 7 型 DNA。
J Med Virol. 2017 Apr;89(4):696-702. doi: 10.1002/jmv.24690. Epub 2016 Sep 27.
6
Human herpesvirus 7 infection associated with central nervous system manifestations.人类疱疹病毒7型感染与中枢神经系统表现相关。
J Pediatr. 1996 Aug;129(2):301-5. doi: 10.1016/s0022-3476(96)70259-7.
7
The predictive value of uvulo-palatoglossal junctional ulcers as an early clinical sign of exanthem subitum due to human herpesvirus 6.
J Clin Virol. 2000 Aug;17(2):83-90. doi: 10.1016/s1386-6532(00)00077-9.
8
Distribution of human herpesvirus 6 and varicella-zoster virus in organs of a fatal case with exanthem subitum and varicella.人疱疹病毒6型和水痘-带状疱疹病毒在一例幼儿急疹和水痘致死病例各器官中的分布
Acta Paediatr Jpn. 1996 Dec;38(6):590-5. doi: 10.1111/j.1442-200x.1996.tb03713.x.
9
Pathogenesis of human herpesvirus 6 (HHV-6).人类疱疹病毒6型(HHV-6)的发病机制。
Infect Agents Dis. 1992 Jun;1(3):149-55.
10
Human herpesvirus-6 infection in neonates: Not protected by only humoral immunity.新生儿人疱疹病毒6型感染:仅靠体液免疫无法提供保护。
Pediatr Int. 2002 Jun;44(3):281-5. doi: 10.1046/j.1442-200x.2002.01562.x.

引用本文的文献

1
Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil.超越虫媒病毒:一项多中心研究,旨在评估巴西里约热内卢皮疹疾病和急性发热病例的鉴别诊断。
PLoS One. 2022 Jul 29;17(7):e0271758. doi: 10.1371/journal.pone.0271758. eCollection 2022.
2
An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.使用国际癌症研究机构(IARC)的致癌性标准对HHV-6作为霍奇金淋巴瘤和脑癌的病原体进行评估。
Infect Agent Cancer. 2019 Nov 5;14:31. doi: 10.1186/s13027-019-0248-3. eCollection 2019.
3
Microbial metagenome of urinary tract infection.
尿路感染的微生物宏基因组。
Sci Rep. 2018 Mar 12;8(1):4333. doi: 10.1038/s41598-018-22660-8.
4
Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan.从日本其他儿科传染病预测川崎病病原体的特征。
Epidemiol Infect. 2016 Feb;144(3):478-92. doi: 10.1017/S0950268815001223. Epub 2015 Jul 23.
5
Clinical impact of primary infection with roseoloviruses.玫瑰疹病毒原发性感染的临床影响。
Curr Opin Virol. 2014 Dec;9:91-6. doi: 10.1016/j.coviro.2014.09.013. Epub 2014 Oct 14.
6
Copy numbers of telomeric repeat sequences of human herpesvirus 6B in clinical isolates: possibility of mixed infections.人疱疹病毒 6B 端粒重复序列的拷贝数:混合感染的可能性。
J Clin Microbiol. 2014 Feb;52(2):419-24. doi: 10.1128/JCM.02192-13. Epub 2013 Nov 13.
7
Human herpesvirus 6A partially suppresses functional properties of DC without viral replication.人类疱疹病毒 6A 可部分抑制 DC 的功能特性,而不进行病毒复制。
PLoS One. 2013;8(3):e58122. doi: 10.1371/journal.pone.0058122. Epub 2013 Mar 5.
8
Human herpesvirus 6 encephalitis.人类疱疹病毒 6 型脑炎。
Curr Infect Dis Rep. 2008 Jul;10(4):292-9. doi: 10.1007/s11908-008-0048-1.
9
Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.原发性感染所致脑脊液中人类疱疹病毒6型DNA水平与染色体病毒整合所致者不同,且对脑炎的诊断有影响。
J Clin Microbiol. 2007 Apr;45(4):1298-304. doi: 10.1128/JCM.02115-06. Epub 2007 Jan 17.
10
Update on human herpesvirus 6 biology, clinical features, and therapy.人疱疹病毒6型生物学、临床特征及治疗进展
Clin Microbiol Rev. 2005 Jan;18(1):217-45. doi: 10.1128/CMR.18.1.217-245.2005.